Britain’s attitude towards its leading edge medicines industry has long been strangely cool.The NHS has preferred cut-price generic drugs to pioneering treatments which could...
Britain’s attitude towards its leading edge medicines industry has long been strangely cool.The NHS has preferred cut-price generic drugs to pioneering treatments which could...